347 related articles for article (PubMed ID: 11276003)
1. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S
J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.
Paavonen K; Mandelin J; Partanen T; Jussila L; Li TF; Ristimaki A; Alitalo K; Konttinen YT
J Rheumatol; 2002 Jan; 29(1):39-45. PubMed ID: 11824969
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
Folpe AL; Veikkola T; Valtola R; Weiss SW
Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray.
Kim HS; Park YH; Lee J; Ahn JS; Kim J; Shim YM; Kim JH; Park K; Han J; Ahn MJ
Cancer; 2010 Feb; 116(3):676-85. PubMed ID: 20052735
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
7. Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.
Witte D; Thomas A; Ali N; Carlson N; Younes M
Anticancer Res; 2002; 22(3):1463-6. PubMed ID: 12168824
[TBL] [Abstract][Full Text] [Related]
8. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
Clarijs R; Schalkwijk L; Hofmann UB; Ruiter DJ; de Waal RM
Cancer Res; 2002 Dec; 62(23):7059-65. PubMed ID: 12460927
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
Tian X; Song S; Wu J; Meng L; Dong Z; Shou C
Biochem Biophys Res Commun; 2001 Aug; 286(3):505-12. PubMed ID: 11511087
[TBL] [Abstract][Full Text] [Related]
10. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
Arinaga M; Noguchi T; Takeno S; Chujo M; Miura T; Uchida Y
Cancer; 2003 Jan; 97(2):457-64. PubMed ID: 12518370
[TBL] [Abstract][Full Text] [Related]
12. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma.
White JD; Hewett PW; Kosuge D; McCulloch T; Enholm BC; Carmichael J; Murray JC
Cancer Res; 2002 Mar; 62(6):1669-75. PubMed ID: 11912138
[TBL] [Abstract][Full Text] [Related]
14. Laminin alpha2 chain (merosin M chain) distribution and VEGF, FGF(2), and TGFbeta1 gene expression in angiogenesis of supraglottic, lung, and breast carcinomas.
Vitolo D; Ciocci L; Cicerone E; Rossi C; Tiboni F; Ferrauti P; Gallo A; Baroni CD
J Pathol; 2001 Sep; 195(2):197-208. PubMed ID: 11592099
[TBL] [Abstract][Full Text] [Related]
15. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
Lymboussaki A; Partanen TA; Olofsson B; Thomas-Crusells J; Fletcher CD; de Waal RM; Kaipainen A; Alitalo K
Am J Pathol; 1998 Aug; 153(2):395-403. PubMed ID: 9708800
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis of lung cancer utilizes existing blood vessels rather than developing new vessels using signals from carcinogenesis.
Uramoto H; Yamada S; Tanaka F
Anticancer Res; 2013 May; 33(5):1913-6. PubMed ID: 23645738
[TBL] [Abstract][Full Text] [Related]
17. Expression of vascular endothelial growth factor-C and its receptor in invasive micropapillary carcinoma of the breast.
Li YS; Kaneko M; Amatya VJ; Takeshima Y; Arihiro K; Inai K
Pathol Int; 2006 May; 56(5):256-61. PubMed ID: 16669874
[TBL] [Abstract][Full Text] [Related]
18. [Expression and clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in non-small cell lung carcinoma].
Lu ZQ; Li HG; Xie DR; Zhang HZ; Shen XM; Zeng YJ; Zeng H
Ai Zheng; 2005 Sep; 24(9):1132-5. PubMed ID: 16159440
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma.
Jüttner S; Wissmann C; Jöns T; Vieth M; Hertel J; Gretschel S; Schlag PM; Kemmner W; Höcker M
J Clin Oncol; 2006 Jan; 24(2):228-40. PubMed ID: 16344322
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node.
Saintigny P; Kambouchner M; Ly M; Gomes N; Sainte-Catherine O; Vassy R; Czernichow S; Letoumelin P; Breau JL; Bernaudin JF; Kraemer M
Lung Cancer; 2007 Nov; 58(2):205-13. PubMed ID: 17686546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
